209 related articles for article (PubMed ID: 15939521)
1. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients.
Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):767-9. PubMed ID: 15939521
[TBL] [Abstract][Full Text] [Related]
2. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).
Ohnuma T; Sakai Y; Maeshima H; Hatano T; Hanzawa R; Abe S; Kida S; Shibata N; Suzuki T; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1905-12. PubMed ID: 18835577
[TBL] [Abstract][Full Text] [Related]
4. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients.
Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M
BMC Psychiatry; 2005 Jan; 5():6. PubMed ID: 15683541
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients.
Fuchs SA; De Barse MM; Scheepers FE; Cahn W; Dorland L; de Sain-van der Velden MG; Klomp LW; Berger R; Kahn RS; de Koning TJ
Eur Neuropsychopharmacol; 2008 May; 18(5):333-8. PubMed ID: 18261886
[TBL] [Abstract][Full Text] [Related]
6. D-serine serum levels in patients with schizophrenia: relation to psychopathology and comparison to healthy subjects.
Hons J; Zirko R; Ulrychova M; Cermakova E; Libiger J
Neuro Endocrinol Lett; 2008 Aug; 29(4):485-92. PubMed ID: 18766161
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
8. CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin).
Miller C; Kirchmair R; Troger J; Saria A; Fleischhacker WW; Fischer-Colbrie R; Benzer A; Winkler H
Biol Psychiatry; 1996 Jun; 39(11):911-8. PubMed ID: 9162202
[TBL] [Abstract][Full Text] [Related]
9. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
[TBL] [Abstract][Full Text] [Related]
10. NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case-control studies.
Brouwer A; Luykx JJ; van Boxmeer L; Bakker SC; Kahn RS
Neurosci Biobehav Rev; 2013 Sep; 37(8):1587-96. PubMed ID: 23792047
[TBL] [Abstract][Full Text] [Related]
11. Selective increase in the extracellular D-serine contents by D-cycloserine in the rat medial frontal cortex.
Fujihira T; Kanematsu S; Umino A; Yamamoto N; Nishikawa T
Neurochem Int; 2007; 51(2-4):233-6. PubMed ID: 17662507
[TBL] [Abstract][Full Text] [Related]
12. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
13. The role of group I metabotropic glutamate receptors in schizophrenia.
Pietraszek M; Nagel J; Gravius A; Schäfer D; Danysz W
Amino Acids; 2007 Feb; 32(2):173-8. PubMed ID: 16699816
[TBL] [Abstract][Full Text] [Related]
14. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.
Bendikov I; Nadri C; Amar S; Panizzutti R; De Miranda J; Wolosker H; Agam G
Schizophr Res; 2007 Feb; 90(1-3):41-51. PubMed ID: 17156977
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment.
Yamamori H; Hashimoto R; Fujita Y; Numata S; Yasuda Y; Fujimoto M; Ohi K; Umeda-Yano S; Ito A; Ohmori T; Hashimoto K; Takeda M
Neurosci Lett; 2014 Oct; 582():93-8. PubMed ID: 25218715
[TBL] [Abstract][Full Text] [Related]
16. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
17. The contribution of the NMDA receptor glycine site to rhythm generation during fictive swimming in Xenopus laevis tadpoles.
Issberner JP; Sillar KT
Eur J Neurosci; 2007 Nov; 26(9):2556-64. PubMed ID: 17970719
[TBL] [Abstract][Full Text] [Related]
18. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
19. Analysis of correlation between serum D-serine levels and functional promoter polymorphisms of GRIN2A and GRIN2B genes.
Iwayama Y; Hashimoto K; Nakajima M; Toyota T; Yamada K; Shimizu E; Itokawa M; Hoshika A; Iyo M; Yoshikawa T
Neurosci Lett; 2006 Feb; 394(2):101-4. PubMed ID: 16266783
[TBL] [Abstract][Full Text] [Related]
20. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
Karasawa J; Hashimoto K; Chaki S
Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
